(HLS)
or Life Sciences Research (LSR) and would not conduct business with them in
the
future or via any third parties."
Brian Brockway
President, CEO and Chairman
Transoma Medical
This is the second company to ditch HLS this year.
Source: SHAC email alerts
Comments
Display the following comment